Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Results presented from FIH study of RBN-2397 in patients with advanced solid tumors

June 8, 2021

Initial first-in-human data presented for TNO-155

June 7, 2021

New phase I/II study evaluates AGuIX gadolinium-based nanoparticles in pancreatic and lung cancers

June 7, 2021

Enrollment begins in phase I study of RO-7300490 as single agent or in combination with atezolizumab

June 7, 2021

Taisho Pharmaceutical presents new MMP-2 inhibitors

June 7, 2021

New ROCK1/2 inhibitors identified at Wuhan LL Science and Technology Development Co.

June 7, 2021

Wuhan Optics Valley Yatai Pharmaceutical Research Institute patents HIF-2-alpha inhibitors

June 7, 2021

Betta Pharmaceuticals patents PI3K inhibitors

June 4, 2021

Algernon launches new clinical research program for ifenprodil in pancreatic cancer

June 4, 2021

Monopar and the National University of Singapore collaborate on development of MNPR-202

June 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...